Here’s Why These Five Stocks Are Surging Today

Oncothyreon Presents at ASCO

Oncothyreon Inc (USA) (NASDAQ:ONTY) is almost 10% in the green after presenting phase 1b results of ONT-380 in combination with T-DM1 at the conference. ONT-380 in combination with T-DM1 is intended for the potential treatment of HER2+ metastatic breast cancer. According to the company’s press release, data from a poster presentation reflected promising efficacy and safety results in the study, where the median progression-free survival time was 8.2 months and an overall response rate was 47%. The majority of adverse events were grade 1. Of the 766 elite funds in our database, 10 funds held shares of Oncothyreon Inc (USA) (NASDAQ:ONTY) at the end of March, down three from the previous quarter.

Command Security Wins a Contract

Nano-cap Command Security Corporation (NYSEMKT:MOC) is 61% higher in the morning after the company announced that it, along with several other companies, will be, ‘eligible to be awarded passenger and baggage screening contracts at any of the over 435 airports that are chosen or elect to utilize private screening companies’. Over 80 teams put up bids, and 15 were selected to perform under the solicitation. If things work out, Command Security Corporation (NYSEMKT:MOC)’s revenue could potentially increase.

Technical Buying Detected At Potash Corporation

Potash Corporation of Saskatchewan (USA) (NYSE:POT) is 4.4% higher as technical buyers snap up shares. Seeing as shares recently closed above several key moving averages, some technical traders are likely buying now for momentum purposes. Value investors could also be buying in anticipation of potentially higher potash prices due to the weaker dollar and hopefully stronger emerging market economies. Of the 766 elite funds we track, 23 funds owned $793.78 million of Potash Corporation of Saskatchewan (USA) (NYSE:POT) and accounted for 5.60% of the float on March 31, versus 26 funds and $768.29 million respectively on December 31.

Disclosure: none